Zogenix (NASDAQ:ZGNX) – SanaCurrents Case Study

By |2018-11-20T15:51:47-05:00July 31st, 2018|Tags: , , , |

California-based company Zogenix (NASDAQ:ZGNX) observed the drug fenfluramine, which had problematic side effects in obesity, and demonstrated it could work [...]